Document is current
Any future updates will be listed below
-
Authors
Dan, Kazunori
Sanada, Junpei
Kimura, Tomohiko
Iwamoto, Yuichiro
Sugisaki, Toshitomo
Iwamoto, Hideyuki
Fushimi, Yoshiro
Nogami, Yuka
Shirakiya, Yoshiko
Shimoda, Masashi
Nakanishi, Shuhei
Kaku, Kohei
Kaneto, Hideaki
- License Information
-
More Information
Article History
Received: 11 September 2025
Accepted: 25 February 2026
First Online: 7 April 2026
Declarations
:
: T.K. has received honoraria for lectures from Novo Nordisk Pharma and Sumitomo Pharma. S. N. has received honoraria for lectures from Novo Nordisk Pharma and Daiichi Sankyo. K.K. has served as an advisor to, received honoraria for lectures from and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku, Taisho Pharma, Kowa, Sumitomo Pharma, Mitsubishi Tanabe Pharma, Astellas and Boehringer Ingelheim. H.K. has received honoraria for lectures, scholarship grants and research grants from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa and Abbott. All other authors have no conflict of interest.
